tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Advertisement

Prescient Therapeutics Limited (PTX) Revenue

Compare
14 Followers

Prescient Therapeutics Limited Revenue

Prescient Therapeutics Limited had a revenue of 3.11M in the quarter ending Jun 30, 2025, with 149.04%. This bring the company's revenue in the last twelve months to 4.36M, Decreased 44.19%. In the fiscal year ending Dec 31, 2025, Prescient Therapeutics Limited had annual revenue of 4.36M with 17.36% growth.
Revenue (ttm)
4.36M
Revenue Growth
P/S Ratio
10.14
Revenue/Employee
AU$1,452,132
Employees
3
Market Cap
AU$44.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
4.36M644.40K+117.36%
Dec 31, 2024
3.71M1.28M+152.88%
Dec 31, 2023
2.43M539.00K+128.53%
Dec 31, 2022
1.89M704.00K+159.41%
Dec 31, 2021
1.19M156.00K+115.16%
Dec 31, 2020
1.03M-619.00K+62.44%
Dec 31, 2019
1.65M708.23K+175.36%
Dec 31, 2018
939.77K-284.47K+76.76%
Dec 31, 2017
1.22M221.74K+122.12%
Dec 31, 2016
1.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis